Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00160758 · ClinicalTrials.gov registry record
Physical Characteristics of Retrieved Massive Allografts
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 18
- Enrollment target
NCT00160758: Completed study, sponsored by University of Florida.
NCT00160758 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00160758 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This purpose of this study is to measure the strength of tissue allografts that have been in the body various lengths of time.
Interventions
- PROCEDURE retrieve massive allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 1999-12 |
| Est. Completion | 2009-09 |
What the finished NCT00160758 record still lists
NCT00160758 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which retrieve massive allograft is the first listed.
NCT00160758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00160758 about?
NCT00160758 is a clinical study titled "Physical Characteristics of Retrieved Massive Allografts". This purpose of this study is to measure the strength of tissue allografts that have been in the body various lengths of time.
What is the current status of trial NCT00160758?
This trial is currently completed. The enrollment target is 18 participants. The study started on 1999-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00160758?
The interventions under investigation include: retrieve massive allograft (PROCEDURE).
Who is sponsoring clinical trial NCT00160758?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia